PLX 2.05 Protalix Biotherapeutics $PLX Hit a 52 we
Post# of 20
![Avatar](/images/ProfileImages/516597884_9056_Emylers.jpg)
PLX Recent Posts: http://investorshangout.com/Protalix-BioThera...PLX-57243/
PLX Protalix Biotherapeutics Recent Headline News
Stock to Watch: Protalix BioTherapeutics Down 5.3% (PLX)
Comtex SmarTrend(R) - Mon Oct 20, 12:42PM CDT
Protalix BioTherapeutics (AMEX
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
5 Stocks Ready to Break Out and Soar Higher
at The Street - Mon Oct 20, 9:24AM CDT
These stocks look ready to break out and trade higher from current levels.
VJET: 12.94 (+0.05), RWLK: 29.98 (-0.02), PLX: 2.05 (-0.07), NDLS: 25.75 (+2.94), RGDO: 0.95 (-0.08)
Stock to Watch: Protalix BioTherapeutics Up 5.0% (PLX)
Comtex SmarTrend(R) - Thu Oct 16, 12:41PM CDT
Protalix BioTherapeutics (AMEX
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Protalix BioTherapeutics, Inc. (PLX) in Focus: Stock Surges 11.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 8:18AM CDT
Protalix BioTherapeutics, Inc. (PLX) was a big mover last session, as the company saw its shares rise by over 7% on the day.
EBS: 22.49 (+0.23), FCSC: 2.67 (-0.09), PLX: 2.05 (-0.07), EPZM: 23.56 (-3.04)
Hot Stock: Protalix BioTherapeutics, Shares Gain 25.0% (PLX)
Comtex SmarTrend(R) - Mon Oct 13, 11:36AM CDT
Protalix BioTherapeutics (AMEX
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Protalix BioTherapeutics names Moshe Manor as CEO
M2 - Mon Sep 29, 6:38AM CDT
The board of directors of Biopharmaceutical company Protalix BioTherapeutics (NYSE MKT
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Protalix BioTherapeutics Appoints Moshe Manor as President and Chief Executive Officer
GlobeNewswire - Mon Sep 29, 12:59AM CDT
Protalix BioTherapeutics, Inc. (NYSE MKT
![](/images/icons/icon_razz.gif)
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07), TEVA: 58.72 (+0.93)
How Protalix BioTherapeutics (PLX) Stock Stands Out in a Strong Industry - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 7:42AM CDT
One stock that might be an intriguing choice for investors right now is Protalix BioTherapeutics as this security in the Healthcare industry space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
PLX: 2.05 (-0.07)
Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 2:12PM CDT
The Dow had a lacklustre week after weakness in energy shares and a series of other concerns dampened investor sentiment.
JNJ: 109.01 (+0.19), GE: 26.36 (+0.54), AMD: 2.76 (-0.04), PFE: 30.04 (unch), PLX: 2.05 (-0.07), MCD: 94.66 (+0.02), MSFT: 48.70 (+0.84), INTC: 33.82 (+0.06), VZ: 50.28 (-0.06)
Protalix BioTherapeutics to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
GlobeNewswire - Thu Sep 04, 6:46AM CDT
Protalix BioTherapeutics, Inc. (NYSE MKT
![](/images/icons/icon_razz.gif)
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 4:00PM CDT
Protalix (PLX) and Pfizer (PFE) announced that the FDA has approved Elelyso injection for pediatric patients suffering from type I Gaucher disease.
GILD: 106.94 (+0.89), SHPG: 199.95 (+1.34), PFE: 30.04 (unch), PLX: 2.05 (-0.07)
Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 8:11AM CDT
Protalix BioTherapeutics, Inc. (PLX) was a big mover last session, as the company saw its shares rise by over 8% on the day.
CBPO: 68.98 (+5.71), CBM: 23.48 (+0.55), GILD: 106.94 (+0.89), PLX: 2.05 (-0.07)
Protalix Announces Conference Call to Discuss ELELYSO Pediatric Approval and Provide Updates on Additional Programs
GlobeNewswire - Thu Aug 28, 4:50PM CDT
Protalix BioTherapeutics, Inc. (NYSE MKT
![](/images/icons/icon_razz.gif)
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Why Protalix BioTherapeutics (PLX) Stock Is Surging Today
at The Street - Thu Aug 28, 1:46PM CDT
Protalix BioTherapeutics (PLX) advanced Thursday after the company co-announced with Pfizer (PFE) that the FDA had approved the expansion of ELELYSO for injection in pediatric patients.
PLX: 2.05 (-0.07)
Protalix BioTherapeutics Up 6.6%, Shares Break Through Resistance (PLX)
Comtex SmarTrend(R) - Thu Aug 28, 12:42PM CDT
Protalix BioTherapeutics (AMEX
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO(TM) (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease
Business Wire - Thu Aug 28, 12:15PM CDT
Pfizer Inc. (NYSE
![](/images/icons/icon_razz.gif)
![](/images/icons/icon_razz.gif)
![](/images/icons/icon_razz.gif)
PFE: 30.04 (unch), PLX: 2.05 (-0.07)
Hot Stock: Protalix BioTherapeutics, Shares Drop 7.5% (PLX)
Comtex SmarTrend(R) - Wed Aug 20, 10:08AM CDT
Protalix BioTherapeutics (AMEX
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Investors look to Lighten Up on Shares of Protalix BioTherapeutics, Shares Down 5.9% (PLX)
Comtex SmarTrend(R) - Wed Aug 13, 11:38AM CDT
Protalix BioTherapeutics (AMEX
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Protalix BioTherapeutics Names Shlomo Yanai as Chairman of the Board of Directors
GlobeNewswire - Thu Jul 24, 7:00AM CDT
Protalix BioTherapeutics, Inc. (NYSE MKT
![](/images/icons/icon_razz.gif)
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting
GlobeNewswire - Fri Jun 27, 6:00AM CDT
Protalix BioTherapeutics, Inc. (NYSE MKT
![](/images/icons/icon_razz.gif)
![](/images/icons/icon_razz.gif)
PLX: 2.05 (-0.07)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)